Agile therapeutics announces 1-for-50 reverse stock split

Princeton, n.j., april 10, 2023 (globe newswire) -- agile therapeutics, inc. (nasdaq: agrx) (“agile”), a women's healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on monday, april 10, 2023. the company's common stock will open for trading on the nasdaq capital market on tuesday, april 11, 2023 on a split-adjusted basis under the current trading symbol "agrx." the reverse stock split was approved by agile's stockholders on march 9, 2023, and is intended to increase the per share trading price of the company's common stock to enable the company to satisfy the minimum bid price requirement for continued listing on nasdaq.
AGRX Ratings Summary
AGRX Quant Ranking